Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.04T, Eli Lilly(LLY) trades at $1,108.93. The stock has a price-to-earnings ratio of 39.85 and currently yields dividends of 0.58%.
On 2026-06-24, Eli Lilly(LLY) stock moved within a range of $1,105.31 to $1,134.74. With shares now at $1,108.93, the stock is trading +0.3% above its intraday low and -2.3% below the session's peak.
Trading activity shows a volume of 902.88K, compared to an average daily volume of 3.03M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
LLY News
The partnership expands the relationship between the two companies as they seek to advance novel drug candidates with global potential by combining their respec...
A controversy has erupted following a media report that U.S. President Donald Trump has been granted early access to Eli Lilly’s (LLY) newest weight-loss drug b...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly (NYSE:LLY) has entered a new multi-target research and license agreement with Abbisko Therapeutics. The partnership focuses on early-stage discovery...
White House has denied reports that President Donald Trump was given access to an experimental weight-loss drug, retatrutide, under the FDA’s “compassionate use...
Eli Lilly (LLY) will be using its cash pile to fund untested drug development strategies in preparation for the expiration of patents on its weight-loss drugs,...
Illumina, Inc. has expanded its Board of Directors from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., Chief Scientific and Product Office...
Eli Lilly (LLY) has announced plans to introduce its weight-loss pill in Europe and the United Kingdom (U.K.) early next year (2027). Unlock powerful investing...
Sangamo Therapeutics Inc. (NASDAQ:SGMO) filed for Chapter 11 bankruptcy protection on Tuesday, as the gene therapy company seeks to sell its assets through a co...
Pharmaceutical giant Eli Lilly (LLY) is undertaking an innovative new strategy that will see it partner with scientists on new drug developments. Unlock powerf...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.